Published • loading... • Updated
Approved Parkinson's treatment wins OK in EU as Hopledo
Summary by Parkinson's News Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Approved Parkinson's treatment wins OK in EU as Hopledo
Hopledo (IPX203), an extended-release formulation of levodopa and carbidopa sold as Crexont in the U.S., has now won approval in the European Union as a treatment for adults with Parkinson’s disease who experience motor fluctuations despite medications. The decision, by the European Commission, was based in large part on trial data showing use of the […] The post Approved Parkinson’s treatment wins OK in EU, to be sold as Hopledo appeared first …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
